Quick Takeaways
- This page summarizes John E. Davis's Form 4 filing for ARTIVION, INC. (AORT).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 04 Jan 2024, 16:22.
Quoteable Key Fact
"John E. Davis filed Form 4 for ARTIVION, INC. (AORT) on 04 Jan 2024."
Ownership activity is grounded in SEC Form 4 disclosures.
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Options Exercise | $221,061 | +13,562 | +11% | $16.30 | 142,295 | 02 Jan 2024 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $244,116 | -13,562 | -9.5% | $18.00 | 128,733 | 02 Jan 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Stock Option (Right to Buy) | Options Exercise | $221,061 | -13,562 | -100% | $16.30 | 0 | 02 Jan 2024 | Common Stock | 13,562 | $16.30 | Direct | F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 23, 2023. |
| F2 | Reflects the price the shares were sold. |
| F3 | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018. |